Skip to content

Certara Drug Interaction Solutions

About Us
- What we do
- How we work
- Our team
- History
- Linked
Our Solutions
Subscription
- Licensing
- Account policies
News
Support
Contact Us
Sign in
DIDB

Contact us

Get in touch

Name (required)

Email (required)

Subject

Message

Δ

Follow us on Linked

Brochures

Why us?

News Categories

Events
New features
News
Posters
Publications

Recent News

Data Curation and Entry in DIDB – August Summary
Understanding the role of CYP3A in the metabolism of kinase inhibitors marketed in the past decade to better manage the risk of clinical drug-drug interactions.
Risk of pharmacokinetic drug-drug interactions with novel drugs approved by the US FDA in 2022: a detailed review of DDI data from NDA documentation.
Certara Drug Interaction Solutions team members to attend the 25th North American ISSX Meeting in Boston
Data Curation and Entry in DIDB – July Summary

Blog
Contact
Privacy

Copyright © 2023 Certara, USA. All Rights Reserved.